Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.53
Delayed Data
As of 3:59pm ET
 +0.015 / +2.91%
Today’s Change
0.34
Today|||52-Week Range
3.98
-66.87%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.52
Today’s open0.51
Day’s range0.45 - 0.53
Volume1,365,393
Average volume (3 months)1,946,435
Market cap$29.5M
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+62.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book9.70

Competitors

 Today’s
change
Today’s
% change
ENUMEnumeral Biomedical ...0.000.00%
--Cell Source Inc+0.14+12.73%
KDUSCadus Corp-0.03-2.29%
ICCCImmuCell Corp+0.02+0.25%
Data as of 3:58pm ET, 07/06/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers